Devices and methods divert blood flow from a first vessel to a second vessel and maintain blood flow in the first vessel. The device includes a first segment and a second segment. The first segment is configured to anchor in the first vessel. The first segment includes a window to allow blood to flow into the first segment, through the window, and distal in the first vessel. The second segment is configured to anchor in the second vessel. The second segment is configured to allow blood to flow into the first segment, through the second segment, and into the second vessel.

The present invention refers to a system and method for opening a concentrate container without the need for a human to directly handle the concentrate container and connecting the concentrate container to a blood treatment device. Aspects of the invention are directed to a container for concentrate and a blood treatment device.

There is described an arteriovenous fistula stent, having a tubular body comprising a series of sinusoidal shaped struts along the length of the tubular body. A plurality of curvilinear connectors extend between and are attached to adjacent struts wherein a first end of a connector is attached to a distal face of a proximal strut apex and a second end of a connector is attached to a proximal face of a distal strut apex. A pair of unconnected strut apexes are between pairs of connected apexes. When the tubular body is in a stowed configuration a proximal aperture and a distal aperture are circular and when the tubular body is in a deployed configuration the distal aperture is oblong or ovoid. There is also described a method for inserting a stent for use in creation of an arteriovenous fistula by identifying a candidate artery and a candidate vein and dissecting the candidate vein. Next, inserting a stent into the vein and creating a breach in the candidate artery at a desired angle and location. Next, introducing the stent and vein into the candidate artery and forming the stent into a curvature angle selected to minimize turbulent blood flow in an anastomosis formed by the vein and the artery. Optionally, there is a step of fastening a distal portion of the stent to the artery.

A monitoring device may include a housing, which may include a distal end, a proximal end, and a fluid pathway extending through the proximal end and distal end. The distal end may include a connector configured to couple to a catheter assembly. The monitoring device may include one or more sensors disposed within the fluid pathway. The sensors may facilitate identification of an occlusion within the catheter assembly.

The invention pertains to a medical device: an ECMO (extracorporeal membrane oxygenation) catheter which can be used during right heart and lung failure. It pertains to a dual lumen catheter with a single port of entry which when in place bypasses the right heart and lungs while completing the veno-arterial circuit.

In one aspect, a system includes a blood treatment machine; a dialyzer configured to be coupled to the blood treatment machine, the dialyzer including a dialyzer housing defining a blood inlet and a blood outlet; a bundle of hollow fibers within an interior of the dialyzer housing; a pumping device drivable to force blood received from the blood inlet through lumens of the bundle of hollow fibers and out the blood outlet; a dialysate inlet port in fluid communication with a dialysate flow path that includes space in the interior of the dialyzer housing between the bundle of hollow fibers; and a dialysate outlet port in fluid communication with the dialysate flow path. The system further includes a fluid conditioning system configured to (i) prepare and supply fresh dialysate to the dialyzer via the dialysate inlet port, and (ii) receive spent dialysate from the dialyzer via the dialysate outlet port, recycle the spent dialysate, and supply the recycled dialysate to the dialyzer via the dialysate inlet port.

A cannula apparatus (100) and method are provided for selective fluid flow in removal and return directions. An outer sheath (102) has proximal (104) and distal (106) outer sheath ends spaced apart by a longitudinal outer sheath body (108) defining an outer sheath lumen (110). At least one fluid removal aperture (112) extends through the outer sheath body. The outer sheath includes a side access aperture (114). An introducer (1534) has proximal (1536) and distal (1538) introducer ends spaced apart by a longitudinal introducer body (1540), which at least partially defines a guidewire channel (1542) longitudinally therealong. The introducer is configured for insertion into the outer sheath lumen with the guidewire channel in fluid communication with the side access aperture. An inner tube (218) has proximal (220) and distal (222) inner tube ends. At least one fluid return aperture (228) is located at least one of at and adjacent the distal inner tube end to place an inner tube lumen in fluid communication with an ambient space.

The present disclosure relates to a set, encompassing or consisting of an effluent bag for receiving effluent generated during a blood treatment having precisely one closeable opening or connection to an outside of the effluent bag, wherein the effluent opening includes a first connector of a first type, or is connected to such an adapter having a line section for guiding a fluid, whereby the line section includes a second connector of the first type and a third connector of a second type, wherein the second type is different than the first type.

A blood filtration system may include blood circuit configured to transmit a fluid within one or more lumens. The system may include an optical sensor configured to couple with the blood circuit. The optical sensor may measure one or more optical characteristics of the fluid in the blood circuit. The one or more optical characteristics may include a first optical characteristic corresponding to a concentration of an imaging substance in the fluid within the blood circuit. The system may include a controller in communication with the optical sensor. The controller may include a sampling module configured to record the one or more optical characteristics. The controller may include a physiological characteristic identification module configured to determine a plasma volume of the patient with the recorded optical characteristics of the imaging substance.

The embodiments of the present disclosure provide a manufacturing method of mitochondria-rich plasma. The mitochondria-rich plasma can increase the cell viability of damaged cells, decrease the cellular senescence level, repair the oxidative damage of cells, and relieve the inflammation of hair follicles so as to achieve the purpose of promoting hair regrowth.